82 related articles for article (PubMed ID: 18383858)
1. Growth inhibition and proapoptotic activity induction by IIF and valproic acid on RA-resistant leukemia cells.
Bartolini G; Orlandi M; Papi A; Ammar K; Tonelli R; Franzoni M; Pession A; Rocchi P; Ferreri AM
Anticancer Res; 2008; 28(1A):283-8. PubMed ID: 18383858
[TBL] [Abstract][Full Text] [Related]
2. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells.
Bartolini G; Orlandi M; Papi A; Ammar K; Guerra F; Ferreri AM; Rocchi P
In Vivo; 2006; 20(6A):729-33. PubMed ID: 17203756
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of retinoid resistance in leukemic cells: possible role of cytochrome P450 and P-glycoprotein.
Kizaki M; Ueno H; Yamazoe Y; Shimada M; Takayama N; Muto A; Matsushita H; Nakajima H; Morikawa M; Koeffler HP; Ikeda Y
Blood; 1996 Jan; 87(2):725-33. PubMed ID: 8555497
[TBL] [Abstract][Full Text] [Related]
4. N-4-hydroxyphenylretinamide enhances retinoic acid-induced differentiation and retinoylation of proteins in the human acute promyelocytic leukemia cell line, NB4, by a mechanism that may involve inhibition of retinoic acid catabolism.
Taimi M; Breitman TR
Biochem Biophys Res Commun; 1997 Mar; 232(2):432-6. PubMed ID: 9125196
[TBL] [Abstract][Full Text] [Related]
5. A novel retinoic/butyric hyaluronan ester for the treatment of acute promyelocytic leukemia: preliminary preclinical results.
Coradini D; Pellizzaro C; Scarlata I; Zorzet S; Garrovo C; Abolafio G; Speranza A; Fedeli M; Cantoni S; Sava G; Daidone MG; Perbellini A
Leukemia; 2006 May; 20(5):785-92. PubMed ID: 16525489
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1.
Tang R; Faussat AM; Majdak P; Perrot JY; Chaoui D; Legrand O; Marie JP
Leukemia; 2004 Jul; 18(7):1246-51. PubMed ID: 15116123
[TBL] [Abstract][Full Text] [Related]
7. The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells.
Trus MR; Yang L; Suarez Saiz F; Bordeleau L; Jurisica I; Minden MD
Leukemia; 2005 Jul; 19(7):1161-8. PubMed ID: 15902297
[TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide circumvents multidrug resistance based on different mechanisms in human leukemia cell lines.
Seo T; Urasaki Y; Takemura H; Ueda T
Anticancer Res; 2005; 25(2A):991-8. PubMed ID: 15868938
[TBL] [Abstract][Full Text] [Related]
9. A retinoid/butyric acid prodrug overcomes retinoic acid resistance in leukemias by induction of apoptosis.
Mann KK; Rephaeli A; Colosimo AL; Diaz Z; Nudelman A; Levovich I; Jing Y; Waxman S; Miller WH
Mol Cancer Res; 2003 Oct; 1(12):903-12. PubMed ID: 14573791
[TBL] [Abstract][Full Text] [Related]
10. Response of retinoic acid-resistant KG1 cells to combination of retinoic acid with diverse histone deacetylase inhibitors.
Savickiene J; Treigyte G; Magnusson KE; Navakauskiene R
Ann N Y Acad Sci; 2009 Aug; 1171():321-33. PubMed ID: 19723072
[TBL] [Abstract][Full Text] [Related]
11. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of retinoic acid and IIF on growth, migration and invasiveness in the U87MG human glioblastoma cell line.
Papi A; Bartolini G; Ammar K; Guerra F; Ferreri AM; Rocchi P; Orlandi M
Oncol Rep; 2007 Oct; 18(4):1015-21. PubMed ID: 17786368
[TBL] [Abstract][Full Text] [Related]
13. Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells.
Zhou DC; Hallam SJ; Lee SJ; Klein RS; Wiernik PH; Tallman MS; Gallagher RE
Cancer Res; 1998 Dec; 58(24):5770-6. PubMed ID: 9865735
[TBL] [Abstract][Full Text] [Related]
14. Retinoids and cancer: antitumoral effects of ATRA, 9-cis RA and the new retinoid IIF on the HL-60 leukemic cell line.
Orlandi M; Mantovani B; Ammar K; Avitabile E; Dal Monte P; Bartolini G
Med Princ Pract; 2003; 12(3):164-9. PubMed ID: 12766334
[TBL] [Abstract][Full Text] [Related]
15. Anti-invasive effects and proapoptotic activity induction by the rexinoid IIF and valproic acid in combination on colon cancer cell lines.
Papi A; Ferreri AM; Guerra F; Orlandi M
Anticancer Res; 2012 Jul; 32(7):2855-62. PubMed ID: 22753748
[TBL] [Abstract][Full Text] [Related]
16. Distinct apoptotic responses in maturation sensitive and resistant t(15;17) acute promyelocytic leukemia NB4 cells. 9-cis retinoic acid induces apoptosis independent of maturation and Bcl-2 expression.
Bruel A; Benoit G; De Nay D; Brown S; Lanotte M
Leukemia; 1995 Jul; 9(7):1173-84. PubMed ID: 7630193
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cells.
Takeshita A; Shinjo K; Naito K; Matsui H; Sahara N; Shigeno K; Horii T; Shirai N; Maekawa M; Ohnishi K; Naoe T; Ohno R
Leukemia; 2005 Aug; 19(8):1306-11. PubMed ID: 15920495
[TBL] [Abstract][Full Text] [Related]
18. Targeting PKC delta-mediated topoisomerase II beta overexpression subverts the differentiation block in a retinoic acid-resistant APL cell line.
McNamara S; Nichol JN; Wang H; Miller WH
Leukemia; 2010 Apr; 24(4):729-39. PubMed ID: 20200558
[TBL] [Abstract][Full Text] [Related]
19. Restoration of retinoid sensitivity by MDR1 ribozymes in retinoic acid-resistant myeloid leukemic cells.
Matsushita H; Kizaki M; Kobayashi H; Ueno H; Muto A; Takayama N; Awaya N; Kinjo K; Hattori Y; Ikeda Y
Blood; 1998 Apr; 91(7):2452-8. PubMed ID: 9516145
[TBL] [Abstract][Full Text] [Related]
20. Retinoid resistance in leukemic cells.
Kizaki M; Ueno H; Matsushita H; Takayama N; Muto A; Awaya N; Ikeda Y
Leuk Lymphoma; 1997 May; 25(5-6):427-34. PubMed ID: 9250812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
